Pharmaceutical companies are committing multi-billion-dollar investments to expand fill-finish and active pharmaceutical ingredient production lines dedicated to metabolic disease treatments.
Contract Manufacturing Demand
In response to unprecedented consumer and clinical demand, major drug developers are outsourcing primary manufacturing steps to specialized Contract Development and Manufacturing Organizations.
Regulatory Streamlining
Health authorities are expediting inspection protocols for newly constructed manufacturing sites to alleviate supply bottlenecks without compromising regulatory safety standards.